Monkeypox, COVID responses share central obstacle

Indonesia Berita Berita

Monkeypox, COVID responses share central obstacle
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 CalMatters
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 63%

California's monkeypox response has been aided and accelerated by lessons learned from COVID, but red tape plagues both.

That was the refrain that popped up repeatedly on Tuesday, when California lawmakers convened for two separate hearings on the two viruses for which Gov. Gavin Newsom has declared a public health state of emergency: COVID-19 and monkeypox.

The key takeaway from the two hearings — which, ironically, took place at the exact same time in the exact same building — was that although California’s monkeypox response has been aided and accelerated by lessons learned from the COVID pandemic, some frustrating problems continue to repeat themselves,“We have shot ourselves in the foot,” state Sen.

Because the drug — federally approved to treat smallpox — hasn’t been cleared by the U.S. Food and Drug Administration to treat monkeypox, it requires hours of paperwork for each patient, along with an ethics review. This “lengthy process has inhibited many medical centers and clinics from being able to offer the drug to many people,” said Dr. Vivek Jain, an associate professor of medicine at San Francisco General Hospital. To state Sen.

“What we learned from COVID is that speed is everything. When we look at the response of monkeypox later on, we’ll see speed is the main thing we take issue with,” Dr. Peter Chin-Hong, an infectious disease specialist at UC San Francisco and a member of the state’s scientific advisory committee for monkeypox,

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

CalMatters /  🏆 261. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

California monkeypox response is bumpy, but builds on some lessons from COVIDCalifornia monkeypox response is bumpy, but builds on some lessons from COVIDMonkeypox tests and vaccines are in short supply as public health officials grapple with red tape and short supplies. Yet some of the processes put in place in response to COVID-19 have helped.
Baca lebih lajut »

Clear results elusive in long COVID studiesClear results elusive in long COVID studiesThere are 26 clinical trials underway to find an effective long COVID treatment — but many are too small or lack the necessary control groups to give clear results.
Baca lebih lajut »

'I didn't really learn anything': COVID grads face college'I didn't really learn anything': COVID grads face collegeHundreds of thousands of recent graduates are heading to college this fall after spending more than half their high school careers dealing with the upheaval of a pandemic.
Baca lebih lajut »

Is COVID losing its fangs and becoming more like the flu?Is COVID losing its fangs and becoming more like the flu?Depending how many cases are assumed given widespread unreported infections confirmed through at-home tests, COVID-19 rates arguably have fallen to levels of a bad flu season. But it’s still …
Baca lebih lajut »

Abrams tests positive for COVID-19, has mild symptomsAbrams tests positive for COVID-19, has mild symptomsDemocratic Georgia gubernatorial candidate Stacey Abrams has COVID-19, her campaign said Wednesday. Abrams campaign spokesperson Alex Floyd said Abrams tested positive for the respiratory illness Wednesday morning after giving a public speech on the economy Tuesday night in Atlanta. Abrams tests daily for COVID-19, Floyd said, and had tested negative on Monday and Tuesday.
Baca lebih lajut »



Render Time: 2025-04-06 02:32:38